Research Associate II/III, Assay Development (Contract)
TLDR
Contribute to gene therapy innovations by testing and troubleshooting molecular biology, ligand binding, and protein characterization assays in a collaborative lab environment.
Work with senior scientific personnel to test and troubleshoot molecular biology, ligand binding and protein characterization assays in a subset of the following categories:
Molecular biology assays including qPCR, ddPCR, and nucleic acid extraction
Ligand binding assays including ELISA
Protein characterization assays including chromatography, electrophoresis, and light scattering assays
Execute experimental plans.
Conduct sample analysis following standard procedures.
Participate in decisions on experimental approaches and interpretation of data.
Author test procedures, documented standard test methods, and SOPs.
Present project status updates to AD team members.
Maintain current knowledge of regulatory requirements for product characterization assays.
Maintain excellent documentation of laboratory activities.
Perform routine lab maintenance.
Other responsibilities may be assigned as needed.
Bachelor’s degree in a life sciences field with 2+ years of relevant experience in a biotech company or fast-paced academic research lab, or an equivalent combination of education and experience.
Experience in generating high quality and reproducible data employing accurate documentation is required.
Knowledge of protein and DNA chemistry is required.
Experience with molecular biology, ligand binding, and/or protein characterization assays is strongly desired.
Experience in AAV-based gene therapy is a plus.
Knowledge of SoftMaxPro, QuantStudio, Empower, and/or other common analytical software is a plus.
Must be a self-starter, proactive, cooperative, and proficient at working both independently and in a small team environment.
Excellent verbal and written communication skills.
Proficient with MS Office and other common office software.
Adverum Biotechnologies is a clinical-stage company dedicated to pioneering gene therapy for prevalent ocular diseases, aiming to provide functional cures that restore vision and prevent blindness. Utilizing its proprietary intravitreal platform, Adverum is developing innovative, single-administration treatments to replace the need for frequent ocular injections, transforming the standard of care and addressing significant unmet medical needs in eye health.